Metabolomic Signature Underlying Motor and Cognitive Dual Decline in the Baltimore Longitudinal Study of Aging

NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Metabolomic Signature Underlying Motor and Cognitive Dual Decline in the Baltimore Longitudinal Study of Aging (i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is HHS-NIH-NIDA-AG-19-122 and the solicitation is issued as an request for quotation (RFQ) This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures; FAR Subpart 13.5- Simplified Procedures for Certain Commercial Items; and FAR Part 12-Acquisition of Commercial Items, and is expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisitiion, Contracts Management Branch Blue on behalf of the National Institute on Aging intends to negotiate and award a purchase order without providing for full and open competition (Including brand-name) to Biocrates Life Sciences AG for services to complete plasma metabolomic assays. This acquisition is conducted as non-competitive for a commercial item or service and is conducted under the authority of the FAR Subpart 13.5-Simplified Procedures for Certain Commercial Items and 13.501 Special documentation requirements and the authority of 41 U.S.C. 1901 and the statutory authority of 13.106-1(b) - Soliciting from a single source. Pursuant to FAR Subpart 13.501 (a) (1) (iv) the rationale for the brand name justification is that it is critical that the data acquired are comparable to those that have been generated previously. In order to ensure this requirement, the proposed assays have to be acquired using the same technical methods and instrumentation. In addition, it is important that these assays be performed in the same laboratory by the technical personnel who acquired the previous metabolomics data on BLSA samples. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2019-01, dated January 22, 2019. (iv) The associated NAICS code 541714 and the small business size standard 1,000 employees. This requirement has no set-aside restrictions. (v) Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the Government as needed to perform the Statement of Work below: (vi) Specific Requirements: The Contractor shall - Perform metabolomic assays on 3021 human plasma samples collected in the BLSA, generate and report data. LEVEL OF EFFORT: A team of researcher s required to complete plasma metabolomic assays and quality control (QC). GOVERNMENT RESPONSIBILITIES The government shall provide adequa te quantities of archived plasma samples to the contractor to enable the performance of the metabolomic assay detailed above. (vii) Period of Performance: The period of performance for this purchase will be one year 7/1/19 - 6/30/20. (viii) The provision at FAR clause 52.212-1, Instructions to Offerors - Commercial Items, applies to this acquisition. (ix) The provision at FAR clause 52.212-2, Evaluation - Commercial Items, applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i) Technical Capability to perform the work, (ii) price; (iii) past performance. Technical and past performance, when combined, are (1) significantly more important than cost or price. (b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s). (c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer's specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (x) The Offerors to include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. (xi) The FAR clause at 52.212-4, Contract Terms and Conditions - Commercial Items, applies to this acquisition. (xii) FAR clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. (xiii) The following additional contract requirement(s) or terms and conditions as determined by the contracting officer are necessary for this acquisition and consistent with customary commercial practices: No additional contact requirements or terms and conditions. (xiv) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xv) Responses to this solicitation must include sufficient information to establish the interested parties' bona-fide capabilities of providing the product or service. The price quote shall include: unit price, list price, shipping and handling costs, delivery days after contract award, delivery terms, prompt payment discount terms, F.O.B. Point (Destination or Origin), product or catalog number(s); product description; and any other information or factors that may be considered in the award decision. Such factors may include: past performance; special features required for effective program performance; trade-in considerations; probable life of the item selected as compared with that of a comparable item; warranty considerations; maintenance availability; and environmental and energy efficiency considerations. Respondents that believe that they are manufacturers or authorized resellers of the brand-name product specified in this announcement must provide, as part of their response: (a) product, catalog, model, and/or part number(s); (b) product description; (c) all relevant information and documentation that the item(s) offered meets the salient physical, functional, or performance characteristics as specified in the purchase description; quantity; estimated price or cost; shipping, handling, and/or installation charges; and delivery date after receipt of order. Responses to this solicitation must include clear and convincing evidence of the offeror's capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. In addition the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov." All responses must be received by May 30, 2019 and reference number HHS-NIH-NIDA-AG-19-122. Responses may be submitted electronically to Jon Gottschalk, jon.gottschalk@nih.gov Fax responses will not be accepted. (xvi) The name and telephone number of the individual to contact for information regarding the solicitation: Jon Gottschalk, 301-443-9456